1 Additional studies should be conducted to functionally evaluate these lo
2 Additional studies should determine whether sex- and age-specific immuno
3 Additional studies should determine whether the method can facilitate ti
4 Analytical studies should be carried out to distinguish between confound
5 Future
cohort studies should aim to confirm this possible effect.
6 Further
controlled studies should evaluate its efficacy and safety.
7 Therefore, RNA
editing studies should complement genome sequence data to understand
8 Biofilm antibiotic
efficacy studies should be assessed using various models and more impo
9 Further studies should be performed to evaluate the toxicity and estr
10 Further studies should determine whether suPAR levels can identify ch
11 Further studies should evaluate the benefits of IP-10 as a triage app
12 Further studies should evaluate the effectiveness of later-generation
13 Further studies should explore the reasons for the particularly high
14 Further studies should investigate clinical benefits and potential ha
15 Further studies should investigate the feasibility of the BCI device
16 of these findings for conservation and management,
further studies should elucidate whether the efficacy of ectoparasite
17 Future studies should address how to scale up use of the resources,
18 Future studies should address the problem of this potential confound
19 Future studies should address whether soluble VCAM-1 is capable of i
20 Future studies should assess the impact of right ventricular protect
21 Future studies should assess the long-term effects of use of the pod
22 Future studies should assess whether therapies to ameliorate pain an
23 Future studies should attempt to replicate these results in other co
24 Future studies should attempt to use multiple tests for each cogniti
25 Future studies should be directed at the cellular component of MMc,
26 Future studies should both rely on molecular approaches and address
27 Future studies should broaden the scope of focal consumers, particul
28 Future studies should complement our study by assessing the associat
29 Future studies should evaluate inter-rater reliability of the SIOP s
30 Future studies should evaluate the safety and efficacy of intravenou
31 Future studies should examine other regulatory drug safety actions,
32 Future studies should examine the effect of anti-HBs serum titers, t
33 Future studies should examine the minimum treatment intensity requir
34 Future studies should explore risk factors for increased AL in Chine
35 Future studies should explore the communications between the glympha
36 Future studies should focus on better defining the role of MAC and f
37 Future studies should focus on understanding the determinants of sex
38 Future studies should investigate putative sex differences in these
39 Future studies should measure multiple biomarkers in each cancer typ
40 Future studies should optimize efficacy and tolerability of salvage
41 ch interventions improve postprandial responses, and
future studies should take into account the acute meal-induced impro
42 ficant effects with alphavbeta5 inhibition; however,
future studies should explore the contribution of vasomotor effects.
43 ic Temporal Generalization task and demonstrate that
future studies should always consider duration range, number of tria
44 Regular follow-up
imaging studies should avoid the use of CT/angio, and particular care
45 ficity to the placental microbiota and placental
microbiome studies should consider regional differences, which may affec
46 We discuss how and why relevant
neuropsychological studies should be carried out.
47 In addition, well-designed and -
powered studies should be conducted for assessing the association bet
48 However, further large
prospective studies should be conducted to explore the critical role of C
49 ting (posterior) emissions, and hence conclusions from
such studies should be interpreted with caution.
50 posed for the conduct of observational and intervention
TBM studies should improve the quality of future research outputs